Case report: Psychedelic-induced seizures captured by intracranial electrocorticography
Benjamin N. Blond, Emmanuelle A. D. Schindler
Frontiers in Neurology June 29, 2023 DOI: 10.3389/fneur.2023.1214969 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | Person with refractory right temporal lobe epilepsy implanted with a responsive neurostimulation (RNS) system |
| Dose | large dose |
| Keywords | Epilepsy Temporal lobe Adverse effect Anesthesia Drug class Electroencephalography |
| Citations | 11 |
| Key findings | Ingestion of a large dose of psychedelic mushrooms coincided with a large increase in typical seizure frequency in a person with refractory right temporal lobe epilepsy. |
Abstract
Classic psychedelics are currently re-emerging as therapeutic agents with unique clinical benefits; however, it is also important to recognize the adverse effects of this drug class. While the risk of seizures with this drug class is known, the literature is lacking in detail. We present a case of psychedelic mushroom-induced seizures in a person with refractory right temporal lobe epilepsy implanted with a responsive neurostimulation (RNS) system. A large increase in typical seizure frequency coincided with the ingestion of a large dose of the mushrooms. This is the first reported case of electrographically confirmed seizures associated with classic psychedelic drug use. With the surge of research and movements toward the clinical application of classic psychedelic compounds, the risk for drug-induced seizures should be considered, including factors such as a history of epilepsy and drug doses and regimens.
Citations in the library
Cited by 11
- 5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk? Psychopharmacology December 11, 2023
- Psychedelics, epilepsy, and seizures: a review Frontiers in Pharmacology January 12, 2024
- Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms. Psychopharmacology August 1, 2024
- Perceived changes in mental health and social engagement attributed to a single psychedelic experience in autistic adults: results from an online survey. Psychopharmacology February 1, 2025
- Do classic psychedelics increase the risk of seizures? A scoping review. European Neuropsychopharmacology August 1, 2024
and 6 more in the library
Cites 10
- Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin. Neurotherapeutics 2021
- Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016 Journal of Psychopharmacology September 5, 2018
- Lysergic Acid Diethylamide: Its Effects on a Male Asiatic Elephant Science December 7, 1962
- Exploratory investigation of a patient‐informed low‐dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double‐blind, placebo‐controlled trial Headache: The Journal of Head and Face Pain November 1, 2022
- Extraction and analysis of indole derivatives from fungal biomass Journal of Basic Microbiology 1994
and 5 more in the library